ILMN - Conference and earnings call announcements

Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research New pangenome representation, default personalization, and machine learning features boost analytical capabilities across applications  SAN DIEGO, April 16, 2026 /PRNewswire/ -- Illumina Inc. (NASDAQ:ILMN) today announced the launch of DRAGEN™ version 4.5 software (v4.5), one of the most substantial expansions of the software's capabilities to date. As genomic researchers contend with complex regions of the genome, degraded samples, and multiomic data types, DRAGEN v4.5 delivers new ways to reduce noise, improve accuracy, and extract biological

Dataset grows to more than 312,000 whole genomes with longitudinal clinical dataGSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data  SAN DIEGO, March 5, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), and Nashville Biosciences, LLC (NashBio), today announced two advancements in scale and depth of the Alliance for Genomic Discovery (AGD or the Alliance). With the addition of Regeneron Genetics Center® (RGC®) as the tenth member, the Alliance can expand the core dataset to 312,000 whole genomes. The Alliance also announced a new initiative: a dataset of 50,000 additional whole genomes with paired proteomic data generated using Illumina® Pro

SAN DIEGO, Feb. 17, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor ConferenceTD Cowen 46th Annual Health Care Conference 2026 on March 3, 2026The fireside chat is scheduled for 12:10pm PT (3:10pm ET).The webcast can be accessed through the Events & Presentations section of Illumina's website at investor.illumina.com. A replay will be archived on Illumina's website for at least 30 days following the event.About IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequenci

SAN DIEGO, Dec. 16, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026The presentation is scheduled for 7:30 a.m. PT (10:30 a.m. ET), with a Q&A session to follow at approximately 7:50 a.m. PT (10:50 a.m. ET). The webcast can be accessed through the Events & Presentations section of Illumina's website at investor.illumina.com. A replay will be archived on Illumina's website for at least 30 days following the event. About Illumina Illumina is improving human health by unlocking the power of the

SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: Wolfe Research Healthcare Conference 2025 on November 19, 2025Fireside chat at 6:20am Pacific Time (9:20am Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technolo

At ASHG, an early access customer from the London Health Sciences Center Research Institute will demonstrate the power of the 5-base genome for accelerating resolution of rare disease cases Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic inquiry, providing researchers with new tool for precision medicine breakthroughs SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced the release of its novel 5-base solution, enabling researchers to pursue broader biological questions with accuracy and ease. The 5-base solution marks a major advancement in scalable multiomic analysis, enabling simultaneous detection of both genomic variants and DN

SAN DIEGO, May 14, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: 41st Annual Bernstein Strategic Decisions Conference on May 28, 2025Fireside chat at 11:30am Pacific Time (2:30pm Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based te

SAN DIEGO, Dec. 4, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2024Presentation at 9:00am Pacific Time (12:00pm Eastern Time) immediately followed by a Q&A Session to begin at approximately 9:20am Pacific Time (12:20pm Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the gen

SAN DIEGO, May 15, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: Bernstein's 40th Annual Strategic Decisions Conference on May 29, 2024Fireside chat at 6:00am Pacific Time (9:00am Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based t

SAN DIEGO, May 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: RBC 2024 Global Healthcare Conference on May 14, 2024Fireside chat at 5:30am Pacific Time (8:30am Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, servi

SAN DIEGO, Dec. 19, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024Presentation at 9:00am Pacific Time (12:00pm Eastern Time) immediately followed by a Q&A Session to begin at approximately 9:20am Pacific Time (12:20pm Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About IlluminaIllumina is improving human health by unlocking the power of the geno

Program aims to address key barriers to genomic sequencing in-country SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs). The program, developed with guidance from customers, funders, and market facilitators including the nonprofit FIND, will provide reduced pricing structures for eligible sequencing products from Illumina to qualified global health funding entities and address key international logistics and supply chain challenges.

Massachusetts Mutual Life Insurance Company (MassMutual) today announced that it is enabling eligible policyowners to gain knowledge about their health through a variety of tools, offerings and research so they can make informed, proactive health decisions that may help them lead longer, healthier lives. The company's efforts are centralized under the MassMutual Health and Wellness Program, which focuses on initiatives that provide policyowners with insights into their potential health risks, empowering them to seek out appropriate interventions and motivate healthy behaviors and lifestyles. "For generations, MassMutual has delivered long-term value to our policyowners by providing holi

SAN DIEGO, Aug. 28, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: Morgan Stanley 21st Annual Global Healthcare Conference on September 11, 2023Fireside chat at 9:55am Pacific Time (12:55pm Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. In 2023, we celebrate 25 years of innovation, which has established us as a global leader

Collaboration Will Evaluate Multi-Cancer Early Detection Screening With the Galleri® Test to Increase Cancer Detection in Underserved Populations Whitman-Walker Institute, a leader in LGBTQ health, research, education and policy with special expertise in HIV care; Cancer Support Community (CSC), a global nonprofit that works to ease the burdens of cancer and eliminate barriers to care through individual and community support, education, and advocacy; and GRAIL, LLC, a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a research collaboration aimed at advancing health equity in cancer screening and care with GalleriⓇ, a multi-cancer early det

SAN DIEGO, Aug. 11, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its vice president of investor relations will be speaking at the following investor conference: UBS MedTech, Tools and Genomics Summit 2023 on August 17, 2023Fireside chat at 9:00am Pacific Time (12:00pm Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com.  A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. In 2023, we celebrate 25 years of innovation, which has established us as a g

SAN DIEGO, June 5, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, today published its annual Corporate Social Responsibility (CSR) Report, highlighting the company's commitment to human health, and the progress made by its environmental, social, and governance (ESG) program in 2022. "Genomics has the ability to improve global health care, sustainability, and equity through better diagnosis and treatment; better representation in genomic data; greater access to personalized medicine; and a deeper understanding o

Strong NovaSeqTM X shipments drove solid Illumina first quarter results; company commits to grow Core Illumina non-GAAP operating margins to 27%[1] in 2025Announces more than $100 million in annualized cost savingsCarl Icahn's campaign is spreading false informationCarl Icahn's unqualified nominees are potentially harmful to Illumina's core business, if electedIllumina requests shareholders to vote the WHITE proxy card FOR all nine of Illumina's director nomineesAnnual Meeting will be held virtually on May 25, 2023 at 10:00 am Pacific Time (1:00 pm Eastern Time)For more information, visit www.IlluminaForward.comSAN DIEGO, May 1, 2023 /PRNewswire/ -- Illumina (NASDAQ:ILMN), a global leader in

SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: 43rd Annual Cowen Health Care Conference on March 7, 2023Fireside chat at 6:50am Pacific Time (9:50am Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com.  A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies,

Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month SAN DIEGO, Jan. 9, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples. The sample cohort is primarily made up of DNA from African Americans, who are currently underrepresented in research for the clinical applications of genomics, including drug target discovery. This cohort will be the largest da

SAN DIEGO, Dec. 19, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023Presentation at 3:45pm Pacific Time (6:45pm Eastern Time) immediately followed by a Q&A Session to begin at approximately 4:05pm Pacific Time (7:05pm Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com.  A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About IlluminaIllumina is improving human health by unlocking the power of the genome

Point32Health, the parent company of Harvard Pilgrim Health Care, and GRAIL, LLC, a health care company with a mission of detecting cancer early when it can be cured, today announced the expansion of their pilot to offer GRAIL's groundbreaking Galleri® multi-cancer early detection blood test to Harvard Pilgrim members at no cost who purchase their insurance on the Maine Health Insurance Marketplace. This expansion is the second phase of a pilot focused on collecting real-world evidence to assess the impact of the Galleri test on health care resource utilization and patient-reported outcomes. "We are proud to be an industry leader in bringing cutting-edge, innovative technologies and servic

SAN DIEGO, Oct. 17, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022. Francis deSouza, President and Chief Executive Officer, Aimee Hoyt, Chief People Officer, John Frank, Chief Public Affairs Officer, and Sharon Vidal, Head of Corporate Social Responsibility, will be joined by Salli Schwartz, Vice President of Investor Relations for a presentation, fireside chat, and Q&A session for investors, analysts, and other interested parties regarding Illumina's ESG strategy and action plans. We

First-of-its-kind Galleri® Multi-Cancer Early Detection blood test can screen for multiple cancers through a single blood draw. DETROIT and MENLO PARK, Calif., Sept. 22, 2022 /PRNewswire/ -- Henry Ford Health, one of the nation's leading academic medical centers recognized for excellence in clinical care, research and education, and GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced Henry Ford Health as the first healthcare provider in Michigan to offer Galleri®, GRAIL's Multi-Cancer Early Detection (MCED) blood test. Henry Ford is among an early group of healthcare providers in the U.S. to offer this MCED test.

SAN DIEGO, April 28, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: BofA Securities 2022 Healthcare Conference on May 12, 2022Fireside Chat at 12:00pm Pacific Time (3:00pm Eastern Time)The live webcast can be accessed under the Investor Info section of Illumina's website under the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and ar

SAN DIEGO, Feb. 21, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: Cowen Health Care Conference on March 7, 2022Fireside Chat at 11:50am Pacific Time (2:50pm Eastern Time)The live webcast can be accessed under the Investor Info section of Illumina's website under the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based tech

SAN DIEGO, Dec. 23, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: J.P. Morgan Annual Healthcare Conference on January 10, 2022 Presentation at 12:45pm Pacific Time (3:45pm Eastern Time) immediately followed by a Q&A Session to begin at approximately 1:05pm Pacific Time (4:05pm Eastern Time)The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our

SAN DIEGO, Aug. 30, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021Fireside Chat at 11:00 am Pacific Time (2:00 pm Eastern Time)The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021 Fireside Chat at 12:00 pm Pacific Time (3:00 pm Eastern Time) The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021 Fireside Chat at 7:30 am Pacific Time / 10:30 am Eastern Time The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customer

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference: Bank of America 2021 Healthcare Conference on May 13, 2021 Fireside Chat at 11:45 am pacific time / 2:45 pm eastern time The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. Replays will be posted on Illumina's website as soon as possible after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving cu

SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Iridia™, Inc., a pioneer in fully integrated DNA-based memory chips, today announced that it has closed its Series B financing at a total of $24 million. The round, led by LifeSci Venture Partners of New York, was substantially oversubscribed, with other prominent participants including Western Digital Capital, JSR Corporation, North Sound Ventures, the Pritzker Vlock Family Office (PVFO), Longley Capital, Validus Growth Investors, ATEM Capital, Tech Coast Angels, and numerous industry-leading high net-worth individuals. Iridia’s disruptive technology is designed to integrate the writing, storage, and read back of massive amounts of data in a m

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast. SVB Leerink Annual Global Healthcare Conference on Thursday, February 25, 2021 Fireside Chat at 12:00pm Pacific Time / 3:00pm Eastern Time Cowen Annual Health Care Conference on Tuesday, March 2, 2021 Fireside Chat at 9:50am Pacific Time / 12:50pm Eastern Time The live webcasts can be accessed under the Investor Info section of the "company" tab at www.illumina.com. Replays will be posted on Illumina’s website as soon as possible after the event and will be available for at least 30 da

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 Presentation at 11:00am Pacific Time immediately followed by a Q&A Session to begin at approximately 11:20am Pacific Time The live webcasts can be accessed under the Investor Info section of the "company" tab at www.illumina.com. Replays will be posted on Illumina’s website as soon as possible after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by un

NEW YORK, Dec. 3, 2020 /PRNewswire/ -- Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients, in order to identify genetic alterations driving disease and potentially reveal previously unidentified therapies for treatment. The initiative, which also includes a collaboration between Weill Cornell Medicine, NewYork-Presbyterian Hospital, and the New York Genome Center (NYGC), aims to evaluate the diagnostic potential of whole-genome sequencing at scale, which allows the interrogation of the full genome sequence o